Bioanalytical Development Services
Smithers Pharmaceutical Development Services, a bioanalytical CRO, supports the development of large molecule therapeutics from discovery through phase IV.
Smithers Appoints a Pharmaceutical Development Services Resource and Operations Optimization Director
Published: 6/17/2024
(Gaithersburg, MD) – June 17, 2024 – Smithers, a leading provider of testing, consulting, information, and compliance services, announces the appointment of Andrea Wakefield as the new Resource and Operations Optimization Director to Smithers Pharmaceutical Development Services Division. Wakefield brings a wealth of knowledge and expertise with over 20 years of experience in regulated bioanalysis with contract research organizations (CROs) and the biotech industry.Wakefield is skilled at streamlining Standard Operational Procedures (SOPs), implementing vendor agreements, and establishing key performance indicators (KPIs).
“We are thrilled to welcome Andrea to our team,” said Christina Satterwhite, PhD, President of Smithers Pharmaceutical Development Services Division. “Her expertise in regulated bioanalysis and operational optimization is instrumental in advancing our commitment to deliver accurate data on time to our clients.” Wakefield holds a Bachelor of Science degree from the University of Ottawa and a Master of Science in Biology from the University of New Brunswick, Canada.
For more information about Smithers Pharmaceutical Development Services Division and its comprehensive services, please visit https://www.smithers.com/bioanalytical or contact infopds@smithers.com
Located in Gaithersburg, Maryland, and Ewing, New Jersey, Smithers Pharmaceutical Development Services Division are GCLP-compliant facilities and CLIA-certified laboratories that support the development of large molecule therapeutics from discovery through post-market, with expertise in bioassays and ultra-sensitivity ligand-binding assays. Our services focus on development, validation, and sample analysis for PK/TK, ADA, bioassays, and fit-for-purpose biomarker studies. Smithers supports developing biologics/monoclonal & polyclonal antibodies, bispecific antibodies, CAR-T, TCR, and Biosimilars. Additionally, Smithers supports Cell and Gene Therapy Studies.
For more information about our CRO services, contact Andrea Wakefield at andrea.wakefield@smithers.com or +1 (240) 961-1465.
For more information about Smithers, please visit https://www.smithers.com/
###
About Smithers:
Founded in 1925 and headquartered in Akron, Ohio, Smithers is a multinational provider of testing, consulting, information, and compliance services. With laboratories and operations in North America, Europe, and Asia, Smithers supports customers in the transportation, life science, packaging, materials, components, consumer, cannabis, dry commodities, and energy industries. Smithers delivers accurate data on time and with high touch by integrating science, technology, and business expertise so customers can innovate with confidence.